title: Experimental therapeutic approaches to peripheral nerve tumors.
abstract: Discovery that the Schwann cell is the primary cell type responsible for both the neurofibroma as well as the schwannoma has proven to represent a crucial milestone in understanding the pathogenesis of peripheral nerve tumor development. This information and related findings have served as a nidus for research aimed at more fully characterizing this family of conditions. Recent discoveries in the laboratory have clarified an understanding of the molecular mechanisms underlying the pathogenesis of benign peripheral nerve tumors. Similarly, the mechanisms whereby idiopathic and syndromic (NF1- and NF2-associated) nerve sheath tumors progress to malignancy are being elucidated. This detailed understanding of the molecular pathogenesis of peripheral nerve tumors provides the information necessary to create a new generation of therapies tailored specifically to the prevention, cessation, or reversal of pathological conditions at the fundamental level of dysfunction. The authors review the data that have helped to elucidate the molecular pathogenesis of this category of conditions, explore the current progress toward exploitation of these findings, and discuss potential therapeutic avenues for future research.
authors.affiliation: Department of Neurosciences and the Center for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Riley
authors.forename: Alejandro
authors.initials: A
authors.lastname: Spiotta
authors.forename: Nicholas
authors.initials: N
authors.lastname: Boulis
mesh_terms: D000818:Animals; D006801:Humans; D009442:Neurilemmoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D009455:Neurofibroma / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D010524:Peripheral Nervous System Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*